Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through development of potentially best-in-class IL-2 therapeutics, today shared positive results from its Phase 1/2 ...

Agenus Inc. ("Agenus") (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, today announced the presentation of new data on two of its promising investigational ...

Xilio is leveraging its proprietary platform to advance a pipeline of research-stage programs for tumor-activated bispecific ...

Adagene (ADAG) announced data at the SITC 39th Annual Meeting, taking place in Houston, Nov. 6 – 10, 2024. The two poster presentations ...

Coya Therapeutics, Inc. (Nasdaq: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance regu ...

Scientists are learning how cancer cells outwit cutting-edge cancer therapies like checkpoint inhibitors—and developing ...

Channel 4's online TV service - now renamed Channel 4 Streaming but it's shortened to C4 – allows you to catch-up on programmes, stream live channels and dip into the archives to watch older shows, ...

In the video, which @bowaledeen posted to Instagram, a woman is seen asking her partner, "What is half of 4 + 4?" The man answers sharply and seemingly confidently, "Four." The woman, on the other ...

The investigation, which is preliminary, will cover an estimated 2.4 million vehicles. Tesla did not immediately respond to a request for comment. The NHTSA investigation comes after four reported ...